October 11, 2024Published by TDP on October 11, 2024Categories OncologyIntroduction to CDK4/6 InhibitorsCDK4/6 inhibitors have emerged as a pivotal component in the treatment of metastatic hormone receptor-positive breast cancer. These inhibitors are recognized as the standard of care, […]